Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s733. https://doi.org/10.25251/8r6ert44